Showing results (671-680 of 713) with videos related to

Sort By:
Pageof 72
Revue Medicale Suisse|July 14, 2017
[Novelties 2016 in pediatrics]Céline J Fischer Fumeaux, Carole Fletgen Richard, Diana Goncalves Pereira Pinto, et al.
Annals of Neurology|June 17, 2022
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple SclerosisReza Rahmanzadeh, Riccardo Galbusera, Po-Jui Lu, et al.
Frontiers in Oncology|May 14, 2023
Optimizing the structure of interdisciplinary tumor boards for effective cancer careFriederike Braulke, Kathrin Kober, Andreas Arndt, et al.
Neuro-Oncology Advances|October 14, 2021
Anesthesia triggers drug delivery to experimental glioma in mice by hijacking caveolar transportLena Spieth, Stefan A Berghoff, Sina K Stumpf, et al.
Neurology|June 5, 2021
Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple SclerosisPietro Maggi, Jens Kuhle, Sabine Schädelin, et al.
Acta Neuropathologica|March 18, 2008
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortiumIrina Alafuzoff, Maria Pikkarainen, Thomas Arzberger, et al.
Glia|October 26, 2018
PI3K: A master regulator of brain metastasis-promoting macrophages/microgliaRaquel Blazquez, Darius Wlochowitz, Alexander Wolff, et al.
Immunity|June 26, 2021
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactionsMarius Schwabenland, Henrike Salié, Jovan Tanevski, et al.
Nature Communications|November 12, 2021
Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathyMatthias Kettwig, Katharina Ternka, Kristin Wendland, et al.
Immunity|October 30, 2025
Single-cell spatial transcriptomic profiling defines a pathogenic inflammatory niche in chronic active multiple sclerosis lesionsRuoqing Feng, Lena Spieth, Lu Liu, et al.
Pageof 72